Cardiol Therapeutics Inc.
For the period ended Dec 31, 2025. Filed Mar 31, 2026.
View on SEC.govAbout this filing
The yearly report of certain Canadian companies, filed under a joint US and Canadian system. It is the main yearly account these companies give US investors, largely as filed in Canada.
FY2025 · Filed Mar 31, 2026
Use the contents to explore the available documents and sections.
Contents
EX-99.2 · 14.Commitments
**14.**Commitments
(i)The Corporation has leased premises with third parties. The minimum committed lease payments, which include the lease liability payments shown as base rent, are approximately as follows:
| | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|
| · · Base rent · · Variable rent · · Total | |||||||||
| 2026 | | $55,376 | | $51,846 | | $107,222 | |||
| 2027 | | | 55,376 | | | 51,846 | | | 107,222 |
| 2028 | | 46,146 | | 43,205 | | 89,351 | |||
| | | $156,898 | | $146,897 | | $303,795 | |||
(ii)The Corporation has signed various agreements with consultants to provide services. Under the agreements, the Corporation has the following remaining commitments.
| | | | |
|---|---|---|---|
| 2026 | | $306,915 | |
| 2027 | | | 34,435 |
| Total | | $341,350 |
| (iii) | Pursuant to the terms of agreements with various other contract research organizations, the Corporation is committed for the following contract research services: |
|---|
| | | | |
|---|---|---|---|
| 2026 | | $2,006,708 | |
| 2027 | | 501,105 | |
| 2028 | | 45,833 | |
| 2029 | | 22,196 | |
| Total | | $2,575,842 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.